Somatic Evolution in Cancer - Somatic Evolution in Therapeutic Resistance - Resistance To BCR-ABL Targeting Drugs

Resistance To BCR-ABL Targeting Drugs

In the case of Gleevec (Imatinib), which targets the BCR-ABL fusion gene in chronic myeloid leukemia, resistance often develops through a mutation that changes the shape of the binding site of the drug. Sequential application of drugs can lead to the sequential evolution of resistance mutations to each drug in turn.

Gleevec is not as selective as was originally thought. It turns out that it targets other tyrosine kinase genes and can be used to control gastrointestinal stromal tumors (GISTs) that are driven by mutations in c-KIT. However, patients with GIST sometimes relapse with additional mutations in c-KIT that make the cancer cells resistant to Gleevec.

Read more about this topic:  Somatic Evolution In Cancer, Somatic Evolution in Therapeutic Resistance

Famous quotes containing the words resistance to, resistance and/or drugs:

    I shall earnestly and persistently continue to urge all women to the practical recognition of the old Revolutionary maxim. “Resistance to tyranny is obedience to God.”
    Susan B. Anthony (1820–1906)

    He made no resistance whatever, and was stabbed in the back.... I must not dwell upon the fearful repast.... Words have no power to impress the mind with the exquisite horror of their reality.
    Edgar Allan Poe (1809–1849)

    If we became students of Malcolm X, we would not have young black men out there killing each other like they’re killing each other now. Young black men would not be impregnating young black women at the rate going on now. We’d not have the drugs we have now, or the alcoholism.
    Spike Lee (b. 1956)